Ryan Asay | Vice President of Corporate Affairs |
David Meek | Chief Executive Officer |
James Christensen | Chief Scientific Officer |
Ben Hickey | Chief Commercial Officer |
Vickie Reed | Chief Accounting Officer |
Tyler Van Biren | Cowen & Company |
Gavin Scott | JPMorgan Chase & Co. |
Andrea Tan | Goldman Sachs Group Inc. |
Evan Seigerman | BMO Capital Markets |
Michael Schmidt | Guggenheim Securities, LLC |
Benjamin Burnett | Stifel, Nicolaus & Company, Inc |
Kevin Strang | Jefferies LLC |
Michael Ulz | Morgan Stanley |
Carly Kenselaar | Citigroup Inc. |
Good afternoon, and welcome to the Mirati Therapeutics Fourth Quarter 2021 Earnings Call. My name is Sarah, and I will be the operator for today's call. All lines have been placed on mute to prevent any background noise. After the conclusion of the speakers' prepared remarks, there will be a question-and-answer session. [Operator Instructions] It is my pleasure to introduce Ryan Asay, Vice President of Corporate Affairs at Mirati.